Safety, pharmacokinetics, and pharmacodynamics of CHF 3381, a novel N-methyl-D-aspartate antagonist, after single oral doses in healthy subjects.
about
Safety, pharmacokinetics, and pharmacodynamics of CHF 3381, a novel N-methyl-D-aspartate antagonist, after single oral doses in healthy subjects.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Safety, pharmacokinetics, and ...... ral doses in healthy subjects.
@en
Safety, pharmacokinetics, and ...... ral doses in healthy subjects.
@nl
type
label
Safety, pharmacokinetics, and ...... ral doses in healthy subjects.
@en
Safety, pharmacokinetics, and ...... ral doses in healthy subjects.
@nl
prefLabel
Safety, pharmacokinetics, and ...... ral doses in healthy subjects.
@en
Safety, pharmacokinetics, and ...... ral doses in healthy subjects.
@nl
P2093
P2860
P356
P1476
Safety, pharmacokinetics, and ...... ral doses in healthy subjects.
@en
P2093
Antoine Tarral
Bruno P Imbimbo
Fabrizia Mariotti
Ivano Rondelli
Laura Fabbri
Philippe Dostert
Yann Guillevic
P2860
P304
P356
10.1177/0091270003256137
P577
2003-08-01T00:00:00Z